首页> 美国卫生研究院文献>Wiley-Blackwell Online Open >A Dogma in Doubt: Hydrolysis of Equatorial Ligands of PtIV Complexes under Physiological Conditions
【2h】

A Dogma in Doubt: Hydrolysis of Equatorial Ligands of PtIV Complexes under Physiological Conditions

机译:怀疑的教条:生理条件下PtIV复合物的赤道配体的水解。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Due to their high kinetic inertness and consequently reduced side reactions with biomolecules, PtIV complexes are considered to define the future of anticancer platinum drugs. The aqueous stability of a series of biscarboxylato PtIV complexes was studied under physiologically relevant conditions. Unexpectedly and in contrast to the current chemical understanding, especially oxaliplatin and satraplatin complexes underwent fast hydrolysis in equatorial position (even in cell culture medium and serum). Notably, the resulting hydrolysis products strongly differ in their reduction kinetics, a crucial parameter for the activation of PtIV drugs, which also changes the anticancer potential of the compounds in cell culture. The discovery that intact PtIV complexes can hydrolyze at equatorial position contradicts the dogma on the general kinetic inertness of PtIV compounds and needs to be considered in the screening and design for novel platinum‐based anticancer drugs.
机译:由于Pt IV 复合物具有很高的动力学惰性并因此减少了与生物分子的副反应,因此可以确定抗癌铂药物的未来。在生理相关条件下研究了一系列双羧基Pt IV 配合物的水稳定性。出乎意料的是,与目前的化学理解相反,特别是奥沙利铂和沙铂复合物在赤道位置(甚至在细胞培养基和血清中)也经历了快速水解。值得注意的是,所得水解产物的还原动力学差异很大,这是激活Pt IV 药物的关键参数,这也改变了化合物在细胞培养中的抗癌能力。完整的Pt IV 配合物可以在赤道位置水解的发现与教条有关Pt IV 化合物的一般动力学惰性相矛盾,因此在新颖的筛选和设计中需要考虑铂类抗癌药。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号